Radcliffe Capital Management’s Envoy Medical Warrant COCHW Stock Holding History

Radcliffe Capital Management’s Portfolio COCHW Stock Details COCHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-166,665	Closed	-$13.7K	–	205
2023 Q3	$13.7K	Hold	166,665	–	–	﹤0.01%	309
2023 Q2	$7.78K	Hold	166,665	–	–	﹤0.01%	452
2023 Q1	$5.87K	Hold	166,665	–	–	﹤0.01%	603
2022 Q4	$1.67M	Hold	166,665	–	–	0.05%	531
2022 Q3	$1.64M	Hold	166,665	–	–	0.04%	741
2022 Q2	$1.63M	Hold	166,665	–	–	0.04%	776
2022 Q1	$1.63M	Hold	166,665	–	–	0.04%	758
2021 Q4	$1.62M	Hold	166,665	–	–	0.04%	648
2021 Q3	$1.62M	Hold	166,665	–	–	0.05%	549
2021 Q2	$1.62M	Buy	+166,665	New	+$119K	0.05%	571

Other funds holding COCHW

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Radcliffe Capital Management's COCHW Position: Q4 2023 in Review

Radcliffe Capital Management sold out of Envoy Medical Warrant (COCHW) in Q4 2023, closing a stake of 166,665 shares — an estimated $13.7K sold.

Radcliffe Capital Management first reported a position in COCHW in Q2 2021 and held it in 10 quarters. The position peaked at $1.67M in Q4 2022. 54 funds tracked by Wall St. Rank hold COCHW as of Q4 2023.

Radcliffe Capital Management reported no remaining Envoy Medical Warrant position as of Q4 2023 after selling out during the quarter.
Radcliffe Capital Management sold 166,665 Envoy Medical Warrant shares in Q4 2023, an estimated $13.7K.
Radcliffe Capital Management first reported a position in Envoy Medical Warrant in Q2 2021 and held it in 10 quarters.
Radcliffe Capital Management's Envoy Medical Warrant position peaked at $1.67M in Q4 2022.
54 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.